Pediatric acute myeloid leukemia: international progress and future directions
- 22 November 2005
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 19 (12), 2025-2029
- https://doi.org/10.1038/sj.leu.2403958
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trialsLeukemia, 2005
- Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group reportLeukemia, 2005
- Causes of death – other than progressive leukemia – in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experienceLeukemia, 2005
- Early Deaths and Treatment-Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML-BFM 93 and AML-BFM 98Journal of Clinical Oncology, 2004
- Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemiaBritish Journal of Haematology, 2004
- Treatment of acute promyelocytic leukemia in children: arsenic or ATRALeukemia, 2004
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2004
- Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93Leukemia, 2003
- Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experienceLeukemia, 2003
- Minimale Resterkrankung bei der akuten myeloischen Leukämie (AML) im Kindesalter - Etablierung und Standardisierung der Immunphänotypisierung in der Therapiestudie AML-BFM-98Klinische Padiatrie, 2002